Patients with T2-high asthma typically respond well to inhaled corticosteroids, which suppress the type 2 inflammatory cascade, and to biologic therapies targeting IL-4, IL-5, and IL-13 [34,35,36,37]. The gene discussed is IL13; the disease is asthma.